MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202521015415 A) filed by Rungta International Skills University; Rungta College Of Engineering & Technology; and Rungta College Of Pharmaceutical Sciences And Research on February 22, 2025, for Ai-Driven Multimodal Imaging Platform For Enhanced Breast Cancer Diagnosis.
Inventors include T M Swathy; Anchal Rani; Shakera Afreen; Deepak Kumar; Nishant Tiwari; Sai Khushant Nagle; Sagar Kumar; Ishvinay Dewangan; and Tanya Verma.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: AI-Driven Multimodal Imaging Platform for Enhanced Breast Cancer Diagnosis This invention describes an advanced diagnostic system for enhanced breast cancer detection and risk stratification. This AI-driven platform integrates multimodal imaging technologies, including digital mammography, ultrasound with elastography, and magnetic resonance imaging (MRI), with patient-specific clinical data such as genetic markers, family history, and prior medical records. The system employs machine learning (ML) and deep learning (DL) algorithms to analyze and synthesize imaging and clinical data, delivering unified diagnostic outputs, malignancy risk scores, and predictive insights. A user-friendly radiologist interface displays annotated imaging, overlays highlighting abnormalities, and decision-support recommendations to streamline workflows and improve diagnostic confidence. By addressing the limitations of standalone imaging modalities and reducing false- positive and false-negative rates, the system enables early-stage cancer detection, particularly in dense breast tissue cases. Designed for clinical environments, this invention enhances diagnostic precision, consistency, and efficiency, ultimately improving patient outcomes and advancing the field of breast cancer diagnostics.
Disclaimer: Curated by HT Syndication.
